Cargando…
The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population
Noninvasive tests are important in the initial risk stratification of people at risk of fibrosis. The recently developed steatosis-associated fibrosis estimator (SAFE) score may have such potential but awaits external validation. METHODS: We analyzed 6973 participants aged 18–80 in the National Heal...
Autores principales: | van Kleef, Laurens A., de Knegt, Robert J., Ayada, Ibrahim, Pan, Qiuwei, Brouwer, Willem Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079343/ https://www.ncbi.nlm.nih.gov/pubmed/37026734 http://dx.doi.org/10.1097/HC9.0000000000000075 |
Ejemplares similares
-
Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study
por: van Kleef, Laurens A., et al.
Publicado: (2021) -
Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
por: van Kleef, Laurens A., et al.
Publicado: (2023) -
Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam Study
por: Xiao, Tian, et al.
Publicado: (2022) -
Reply to: “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
por: van Kleef, Laurens A., et al.
Publicado: (2022) -
Dissecting the multifaceted impact of statin use on fatty liver disease: A multidimensional study
por: Ayada, Ibrahim, et al.
Publicado: (2022)